Your browser doesn't support javascript.
loading
A United States regulator's perspective on the ongoing chlorofluorocarbon transition.
Meyer, R J.
Affiliation
  • Meyer RJ; Division of Pulmonary and Allergy Drug Products, and the CFC Work Group, Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, MD 20857, USA.
J Allergy Clin Immunol ; 104(6): S236-8, 1999 Dec.
Article in En | MEDLINE | ID: mdl-10588981
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: United States Food and Drug Administration / Nebulizers and Vaporizers / Chlorofluorocarbons Type of study: Prognostic_studies Country/Region as subject: America do norte Language: En Journal: J Allergy Clin Immunol Year: 1999 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: United States Food and Drug Administration / Nebulizers and Vaporizers / Chlorofluorocarbons Type of study: Prognostic_studies Country/Region as subject: America do norte Language: En Journal: J Allergy Clin Immunol Year: 1999 Document type: Article Affiliation country: Country of publication: